Oral arguments in Cortex Television v. New York State Dept Health, Index No. 318612 (Sup. Ct., Albany Cnty. 2022)

October 18, 2023 Continue reading →

Posted in - Policy | Leave a comment

Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity

September 1, 2023- by Sucharit Bhakdi, MD et al Continue reading →

Posted in - Biotech, - Pharma, - Reviews, books, devices, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology, Pediatrics | Leave a comment

Ivermectin works against COVID in double blind, randomized, controlled trial

May 2, 2023- by Steven E. Greer, MD

A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well. Continue reading →

Posted in - Biotech, - Generics, - Pharma, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine | Leave a comment

Did the COVID vaccines change the human genome?

May 11, 2023- by Steven E. Greer, MD

I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on the Joe Piscopo show, June 3, 2020, before the vaccines were on the market: Continue reading →

Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology | Leave a comment

That time I worked with Lucas Films to push digital cameras into the mainstream

November 11, 2023- by Steven E. Greer, MD Continue reading →

Posted in - Medical Devices, - Opinion, Plastic surgery | Leave a comment

Federal appeals court rules that our federal government violated the First Amendment during the pandemic

September 8, 2023- by Steven Greer (pro se litigator extraordinaire) Continue reading →

Posted in - Opinion, CDC, CMS, Congress, FDA, NIH | Leave a comment

The Healthcare Channel hits 10

February 3, 2017- by Steven E. Greer, MD I don’t recall the exact date, but it was sometime during the summer of 2006, when I was daydreaming Continue reading →

Posted in - Opinion | Leave a comment

Joe Piscopo interviews Steven E. Greer, MD: 5-22-2020

May 22, 2020 Continue reading →

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Pulmonology | Leave a comment

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer, Continue reading →

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer,

Posted in - Biotech, - Generics, FDA | Leave a comment

WABC radio morning show Bernie & Sid interviews Steven E. Greer, MD: May 21, 2020

May 21, 2020- by Steven E. Greer, MD

In this segment, Continue reading →

Posted in - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pulmonology | Leave a comment

I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show

March 23, 2020- I updated Joe Piscopo today, focusing on the new drugs to treat coronavirus. Continue reading →

Posted in - Opinion, - Policy, CDC, Congress, Emergency medicine, Infectious disease, NIH | Leave a comment

New treatment paradigm for C. Diff colitis

March 31, 2010- Produced and interviewed by Steven E. Greer, MD

New drugs Continue reading →

Posted in CDC, Gastroenterology and liver, General surgery, Infectious disease, Michigan, Primary care medicine | Leave a comment

Celiac disease is not reduced by breast feeding or delaying the introduction of gluten

October 19, 2014- Interviewed by Steven E. Greer, MD

Alessio Fasano, MD of Harvard discusses his 10-year-long study in children testing whether the Continue reading →

Posted in - NEJM, Gastroenterology and liver, Harvard, Pediatrics, Primary care medicine | 1 Comment

Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs

October 24, 2010- Gordon Guyatt, MD, epidemiologist, internist, and biostatistician at McMaster Continue reading →

Posted in Cardiology, FDA, McMaster University | Leave a comment

Why are suicide rates increasing along with increased usage of antidepressants?

June 8, 2018- Fox News’ Tucker Carlson interviewed author Johan Hari about his book Lost Connections and the Continue reading →

Posted in - Pharma, - Policy, CDC, FDA, Neurology, Primary care medicine, Psychology Psychiatry | Leave a comment

Senator Angus King discusses his bill to make medical device pricing transparent to the public

July 9, 2014- Interviewed by Steven E. Greer, MD

Senator Angus King from Maine has proposed a a bill that would make the pricing of medical devices Continue reading →

Posted in - Medical Devices, - Policy, Congress | Leave a comment

The truly scary consequence of this “pandemic” is the erosion of our civil rights

Update May 18, 2023-

Three years too late, the cowardly Supreme Court pretends it was outraged all along. The Court issued a decision authored by Justice Gorsuch. In the case of Arizona, et al. v. Alejandro Mayrokas, et al, the decision stated: Continue reading →

Posted in - Opinion, - Policy, Congress | Leave a comment

COVID mRNA gene therapies never worked and are now clearly harmful

November 5, 2021- by Steven E. Greer, MD

In the most prestigious journal in all of science, Science magazine posted this article. The authors studied vaccine efficacy over time in VA patients. The effectiveness at preventing COVID infections fell to as low as 13%. Continue reading →

Posted in - Biotech, - Opinion, - Pharma, - Policy | Leave a comment

Early stoppage of clinical trials

April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results Continue reading →

Posted in Cardiac surgery, FDA, McMaster University | Leave a comment